CEBP  Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rebbeck, T. R.
Right arrow Articles by Malkowicz, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rebbeck, T. R.
Right arrow Articles by Malkowicz, S. B.
Cancer Epidemiology Biomarkers & Prevention Vol. 8, 283-287, April 1999
© 1999 American Association for Cancer Research

Glutathione S-Transferase-µ (GSTM1) and -{theta} (GSTT1) Genotypes in the Etiology of Prostate Cancer1

Timothy R. Rebbeck2, Amy H. Walker, Julie M. Jaffe, David L. White, Alan J. Wein and S. Bruce Malkowicz

Departments of Biostatistics and Epidemiology [T. R. R., A. H. W., J. M. J., D. L. W.] and Urology [A. J. W., S. B. M.], University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104

The glutathione S-transferases (GSTs) are involved in the metabolism of numerous potential prostate carcinogens. Common homozygous germ-line deletions exist in the genes that encode GST-|gm (GSTM1) and GST-{theta} (GSTT1) and preclude enzyme expression. To evaluate whether GSTM1 and/or GSTT1 contribute to prostate cancer (CaP) etiology, we studied 237 incident CaP cases and 239 age- and race-matched controls. The probability of having CaP was increased in men who had nondeleted (functional) genotypes at GSTT1 (odds ratio, 1.83; 95% confidence interval, 1.19–2.80) but not GSTM1 (odds ratio, 1.07; 95% confidence interval, 0.74–1.55). No interaction of these genes in CaP etiology was observed. GST-{theta} is highly expressed in the prostate and can produce genotoxic effects upon exposure to specific carcinogens. These results suggest that GSTT1 is associated with CaP risk.




This article has been cited by other articles:


Home page
FASEB J.Home page
J. M. Marzec, J. D. Christie, S. P. Reddy, A. E. Jedlicka, H. Vuong, P. N. Lanken, R. Aplenc, T. Yamamoto, M. Yamamoto, H.-Y. Cho, et al.
Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury
FASEB J, July 1, 2007; 21(9): 2237 - 2246.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
N. L. Nock, D. Tang, A. Rundle, C. Neslund-Dudas, A. T. Savera, C. H. Bock, K. G. Monaghan, A. Koprowski, N. Mitrache, J. J. Yang, et al.
Associations between Smoking, Polymorphisms in Polycyclic Aromatic Hydrocarbon (PAH) Metabolism and Conjugation Genes and PAH-DNA Adducts in Prostate Tumors Differ by Race
Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1236 - 1245.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
N. L. Nock, X. Liu, M. S. Cicek, L. Li, F. Macarie, B. A. Rybicki, S. J. Plummer, G. T. MacLennan, G. Casey, and J. S. Witte
Polymorphisms in polycyclic aromatic hydrocarbon metabolism and conjugation genes, interactions with smoking and prostate cancer risk.
Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 756 - 761.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. K. Nam, W. W. Zhang, M. A.S. Jewett, J. Trachtenberg, L. H. Klotz, M. Emami, L. Sugar, J. Sweet, A. Toi, and S. A. Narod
The Use of Genetic Markers to Determine Risk for Prostate Cancer at Prostate Biopsy
Clin. Cancer Res., December 1, 2005; 11(23): 8391 - 8397.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. K. Nam, W. W. Zhang, J. Trachtenberg, M. A. S. Jewett, M. Emami, D. Vesprini, W. Chu, M. Ho, J. Sweet, A. Evans, et al.
Comprehensive Assessment of Candidate Genes and Serological Markers for the Detection of Prostate Cancer
Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1429 - 1437.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
R. K. Nam, W. W. Zhang, J. Trachtenberg, E. Diamandis, A. Toi, M. Emami, M. Ho, J. Sweet, A. Evans, M. A.S. Jewett, et al.
Single Nucleotide Polymorphism of the Human Kallikrein-2 Gene Highly Correlates With Serum Human Kallikrein-2 Levels and in Combination Enhances Prostate Cancer Detection
J. Clin. Oncol., June 15, 2003; 21(12): 2312 - 2319.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
R. Aplenc, H. Zhao, T. R. Rebbeck, and K. J. Propert
Group Sequential Methods and Sample Size Savings in Biomarker-Disease Association Studies
Genetics, March 1, 2003; 163(3): 1215 - 1219.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. H. van Gils, R. M. Bostick, M. C. Stern, and J. A. Taylor
Differences in Base Excision Repair Capacity May Modulate the Effect of Dietary Antioxidant Intake on Prostate Cancer Risk: An Example of Polymorphisms in the XRCC1 Gene
Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1279 - 1284.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. P. Gelmann, D. J. Steadman, J. Ma, N. Ahronovitz, H. J. Voeller, S. Swope, M. Abbaszadegan, K. M. Brown, K. Strand, R. B. Hayes, et al.
Occurrence of NKX3.1 C154T Polymorphism in Men with and without Prostate Cancer and Studies of Its Effect on Protein Function
Cancer Res., May 1, 2002; 62(9): 2654 - 2659.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. L. Goode, J. L. Stanford, M. A. Peters, M. Janer, M. Gibbs, S. Kolb, M. D. Badzioch, L. Hood, E. A. Ostrander, and G. P. Jarvik
Clinical Characteristics of Prostate Cancer in an Analysis of Linkage to Four Putative Susceptibility Loci
Clin. Cancer Res., September 1, 2001; 7(9): 2739 - 2749.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C.-A. Sun, L.-Y. Wang, C.-J. Chen, S.-N. Lu, S.-L. You, L.-W. Wang, Q. Wang, D.-M. Wu, and R. M. Santella
Genetic polymorphisms of glutathione S-transferases M1 and T1 associated with susceptibility to aflatoxin-related hepatocarcinogenesis among chronic hepatitis B carriers: a nested case-control study in Taiwan
Carcinogenesis, August 1, 2001; 22(8): 1289 - 1294.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
S. A. Geisler and A. F. Olshan
GSTM1, GSTT1, and the Risk of Squamous Cell Carcinoma of the Head and Neck: A Mini-HuGE Review
Am. J. Epidemiol., July 15, 2001; 154(2): 95 - 105.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. A. Kanetsky, R. Holmes, A. Walker, D. Najarian, J. Swoyer, D. Guerry, A. Halpern, and T. R. Rebbeck
Interaction of Glutathione S-Transferase M1 and T1 Genotypes and Malignant Melanoma
Cancer Epidemiol. Biomarkers Prev., May 1, 2001; 10(5): 509 - 513.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. N. Kelada, S. L. R. Kardia, A. H. Walker, A. J. Wein, S. B. Malkowicz, and T. R. Rebbeck
The Glutathione S-Transferase-{micro} and -{{theta}} Genotypes in the Etiology of Prostate Cancer: Genotype-Environment Interactions with Smoking
Cancer Epidemiol. Biomarkers Prev., December 1, 2000; 9(12): 1329 - 1334.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1999 by the American Association for Cancer Research.